BMC Public Health (Jan 2011)

Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care

  • Hernández Susana,
  • Iglesias Piñeiro M,
  • Sanz Yolanda,
  • Yepes Jeannet,
  • Uriarte Beatriz,
  • Vello Cuadrado Rocío A,
  • González Paulino,
  • Rojas Giraldo María J,
  • Horcajuelo Jesús,
  • del Pozo Marta,
  • Teira Blanca,
  • Rodríguez-Moñino Ana,
  • Díaz Yolanda,
  • De-Alba Romero Cristina,
  • Wiesmann Elisa,
  • Barrientos Ricardo,
  • Arenas Laura,
  • del Canto De-Hoyos Alonso M,
  • Escriva Ferrairo Rosa A,
  • Del-Alamo Rodríguez Justo M,
  • Fernández Jesús,
  • Cuesta Teresa,
  • García-de-Blas González Francisca,
  • Del-Cura González Isabel,
  • Alonso Fernando,
  • González González Ana I,
  • Fernández Alicia,
  • Carballo Carmen,
  • López Ana,
  • Morales Fernanda,
  • Martínez López Dolores

DOI
https://doi.org/10.1186/1471-2458-11-63
Journal volume & issue
Vol. 11, no. 1
p. 63

Abstract

Read online

Abstract Background Vaginitis is a common complaint in primary care. In uncomplicated candidal vaginitis, there are no differences in effectiveness between oral or vaginal treatment. Some studies describe that the preferred treatment is the oral one, but a Cochrane's review points out inconsistencies associated with the report of the preferred way that limit the use of such data. Risk factors associated with recurrent vulvovaginal candidiasis still remain controversial. Methods/Design This work describes a protocol of a multicentric prospective observational study with one year follow up, to describe the women's reasons and preferences to choose the way of administration (oral vs topical) in the treatment of not complicated candidal vaginitis. The number of women required is 765, they are chosen by consecutive sampling. All of whom are aged 16 and over with vaginal discharge and/or vaginal pruritus, diagnosed with not complicated vulvovaginitis in Primary Care in Madrid. The main outcome variable is the preferences of the patients in treatment choice; secondary outcome variables are time to symptoms relief and adverse reactions and the frequency of recurrent vulvovaginitis and the risk factors. In the statistical analysis, for the main objective will be descriptive for each of the variables, bivariant analysis and multivariate analysis (logistic regression).. The dependent variable being the type of treatment chosen (oral or topical) and the independent, the variables that after bivariant analysis, have been associated to the treatment preference. Discussion Clinical decisions, recommendations, and practice guidelines must not only attend to the best available evidence, but also to the values and preferences of the informed patient.